Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5204533
Max Phase: Preclinical
Molecular Formula: C51H89N15O12S2
Molecular Weight: 1168.50
Associated Items:
ID: ALA5204533
Max Phase: Preclinical
Molecular Formula: C51H89N15O12S2
Molecular Weight: 1168.50
Associated Items:
Canonical SMILES: CC(C)CCSSC[C@@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O
Standard InChI: InChI=1S/C51H89N15O12S2/c1-27(2)17-23-79-80-26-32(56)42(69)65-41(30(6)68)51(78)62-35(14-20-54)44(71)61-37-16-22-57-50(77)40(29(5)67)66-47(74)36(15-21-55)59-43(70)33(12-18-52)60-48(75)38(24-28(3)4)63-49(76)39(25-31-10-8-7-9-11-31)64-45(72)34(13-19-53)58-46(37)73/h7-11,27-30,32-41,67-68H,12-26,52-56H2,1-6H3,(H,57,77)(H,58,73)(H,59,70)(H,60,75)(H,61,71)(H,62,78)(H,63,76)(H,64,72)(H,65,69)(H,66,74)/t29-,30-,32-,33+,34+,35+,36+,37+,38+,39-,40+,41+/m1/s1
Standard InChI Key: NEMKHDOVUYDGRK-GDHUNXLASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1168.50 | Molecular Weight (Monoisotopic): 1167.6257 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Slingerland CJ, Wesseling CMJ, Innocenti P, Westphal KGC, Masereeuw R, Martin NI.. (2022) Synthesis and Evaluation of Polymyxins Bearing Reductively Labile Disulfide-Linked Lipids., 65 (23.0): [PMID:36399613] [10.1021/acs.jmedchem.2c01528] |
Source(1):